Effect size of reference memory deficits in the Morris water maze in Tg2576 mice

Behavioural Brain Research

Volumn 212, Issue 1, 2010, Pages 115-120

  Reed, Miranda N ^a   Liu, Peng ^a   Kotilinek, Linda A ^a   Ashe, Karen H ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Effect size; Morris water maze; Sample size; Tg2576

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EFFECT SIZE; MAZE TEST; MEMORY DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TG2576 MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MUTATION; SEX FACTORS;

EID: 77952883191     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.03.037     Document Type: Article

References (31)

1. Wenk G.L. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003, 64(Suppl. 9):7-10.
2. Tiraboschi P., Hansen L.A., Thal L.J., Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 2004, 62:1984-1989.
3. Rapp M.A., Reischies F.M. Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am J Geriatr Psychiatry 2005, 13:134-141.
4. Hsiao K. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
5. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSwe transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 1997, 56:965-973.
6. Frautschy S.A., Yang F., Irizarry M., et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998, 152:307-317.
7. Ashe K.H. Mechanisms of memory loss in Aβ and tau mouse models. Biochem Soc Trans 2005, 33:591-594.
8. King D.L., Arendash G.W., Crawford F., Sterk T., Menendez J., Mullan M.J. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 1999, 103:145-162.
9. Chapman P.F., White G.L., Jones M.W., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 1999, 2:271-276.
10. Pompl P.N., Mullan M.J., Bjugstad K., Arendash G.W. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. J Neurosci Methods 1999, 87:87-95.
11. Morgan D., Diamond D.M., Gottschall P.E., et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000, 408:982-985.
12. King D.L., Arendash G.W. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 2002, 75:627-642.
13. Arendash G.W., Lewis J., Leighty R.E., et al. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 2004, 1012:29-41.
14. Westerman M.A., Cooper-Blacketer D., Mariash A., et al. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2002, 22:1858-1867.
15. Deacon R.M.J., Cholerton L.L., Talbot K., et al. Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav Brain Res 2008, 189:126-138.
16. Ishida A., Furukawa K., Keller J.N., Mattson M.P. Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 1997, 8:2133-2137.
17. Meziane H., Dodart J.C., Mathis C., et al. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA 1998, 95:12683-12688.
18. Ma H., Lesne S., Kotilinek L., et al. Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci USA 2007, 104:8167-8172.
19. Laird F.M., Cai H., Savonenko A.V., et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 2005, 25:11693-11709.
20. Lesne S., Koh M.T., Kotilinek L., et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
21. Walsh D.M., Klyubin I., Fadeeva J., et al. Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit hippocampal long-term potential in vivo. Nat Biotechnol 2002, 416:535-539.
22. Fitzjohn S.M., Morton R.A., Kuenzi F., et al. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci 2001, 21:4691-4698.
23. Lambert M., Barlow A., Chromy B., et al. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998, 95:6448-6453.
24. Hsia A.Y., Masliah E., McConlogue L., et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 1999, 96:3228-3233.
25. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (β) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001, 21:372-381.
26. Maei H.R., Zaslavsky K., Teixeira CtM, Frankland P.W. What is the most sensitive measure of water maze probe test performance?. Front Integrat Neurosci 2009, 3:4.
27. Cohen J. A power primer. Psychol Bull 1992, 112:155-159.
28. Wang J., Ho L., Zhao W., et al. Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 2008, 28:6388-6392.
29. Ribes D., Colomina M.T., Vicens P., Domingo J.L. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol 2008, 214:293-300.
30. Díaz-Ruiz C., Wang J., Ksiezak-Reding H., et al. Role of hypertension in aggravating Aβ neuropathology of AD type and tau-mediated motor impairment. Cardiovasc Psychiatry Neurol 2009, 2009. 107286.
31. Wolfer D.P., Madani R., Valenti P., Lipp H.P. Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav 2001, 73:745-753.